Jane C Davies Selected Research

Anti-Bacterial Agents (Antibiotics)

3/2023	Lytic Bacteriophage Is a Promising Adjunct to Common Antibiotics across Cystic Fibrosis Clinical Strains and Culture Models of Pseudomonas aeruginosa Infection.
11/2022	New concepts in antimicrobial resistance in cystic fibrosis respiratory infections.
1/2022	Clinical characteristics of Pseudomonas and Aspergillus co-infected cystic fibrosis patients: A UK registry study.
3/2021	Variability in Bacteriophage and Antibiotic Sensitivity in Serial Pseudomonas aeruginosa Isolates from Cystic Fibrosis Airway Cultures over 12 Months.
1/2020	The future of cystic fibrosis care: a global perspective.
1/2017	Current and future therapies for Pseudomonas aeruginosa infection in patients with cystic fibrosis.
5/2009	Bugs, biofilms, and resistance in cystic fibrosis.
6/2007	Emerging and unusual gram-negative infections in cystic fibrosis.
4/2006	Exploring the mechanisms of macrolides in cystic fibrosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jane C Davies Research Topics

Disease

67	Cystic Fibrosis (Mucoviscidosis) 04/2024 - 09/2005
14	Infections 03/2023 - 07/2004
12	Lung Diseases (Lung Disease) 10/2023 - 09/2008
10	Inflammation (Inflammations) 04/2024 - 03/2013
4	Pseudomonas Infections 03/2023 - 01/2017
3	Persistent Infection 01/2020 - 05/2009
3	Respiratory Tract Diseases (Respiratory Tract Disease) 09/2018 - 03/2013
2	Fibrosis (Cirrhosis) 01/2023 - 01/2017
2	Coinfection 01/2022 - 10/2021
2	Multiple Sclerosis 01/2022 - 11/2017
2	Cough 01/2021 - 01/2021
2	Weight Gain 08/2018 - 06/2013
1	Gastroesophageal Reflux (GERD) 10/2023
1	Pain (Aches) 10/2023
1	Rare Diseases (Rare Disease) 10/2023
1	Rhinosinusitis 09/2023
1	Headache (Headaches) 11/2021
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 11/2021
1	Primary Headache Disorders 01/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021
1	Necrosis 01/2020
1	Sleep Apnea Syndromes (Sleep Apnea) 01/2020
1	Malnutrition (Nutritional Deficiencies) 01/2020
1	Vitamin D Deficiency 01/2018
1	Chronic Cough 01/2018
1	Constipation 01/2018
1	Kaposi Varicelliform Eruption (Eczema Herpeticum) 01/2018
1	Intestinal Obstruction (Obstruction, Intestinal) 01/2018
1	Communicable Diseases (Infectious Diseases) 12/2017

Drug/Important Bio-Agent (IBA)

17	ivacaftorIBA 04/2024 - 06/2013
15	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 10/2023 - 11/2010
10	ivacaftor drug combination tezacaftorIBA 11/2023 - 11/2017
9	Anti-Bacterial Agents (Antibiotics)IBA 03/2023 - 04/2006
9	Proteins (Proteins, Gene)FDA Link 01/2023 - 07/2004
8	Biomarkers (Surrogate Marker)IBA 04/2024 - 04/2007
7	ChloridesIBA 11/2023 - 10/2018
5	elexacaftorIBA 11/2023 - 07/2022
4	lumacaftorIBA 08/2023 - 01/2015
3	Tobramycin (Nebcin)FDA LinkGeneric 01/2022 - 09/2005
3	tezacaftorIBA 01/2021 - 11/2017
2	AnionsIBA 01/2022 - 01/2017
2	Glatiramer Acetate (Copaxone)FDA Link 01/2022 - 11/2017
2	posaconazole FDA Link 11/2021 - 01/2020
2	AlginatesIBA 10/2020 - 01/2017
2	OligosaccharidesIBA 10/2020 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 12/2017 - 09/2015
2	Liposomes (Liposome)IBA 12/2015 - 09/2015
2	LipidsIBA 12/2013 - 07/2010
1	Nucleic AcidsIBA 10/2023
1	Peptides (Polypeptides)IBA 01/2022
1	Epithelial Sodium ChannelsIBA 01/2022
1	TabletsIBA 11/2021
1	riociguatIBA 11/2021
1	SodiumIBA 11/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	hypothiocyanous acidIBA 12/2020
1	Oxidants (Oxidizing Agents)IBA 12/2020
1	Hypochlorous Acid (Hypochlorite)IBA 12/2020
1	PowdersIBA 10/2020
1	Anti-Infective Agents (Microbicides)IBA 10/2020
1	CytokinesIBA 01/2020
1	Cephalosporins (Cephalosporin Antibiotics)IBA 01/2020
1	prolyl-glycyl-prolineIBA 01/2020
1	C-Reactive ProteinIBA 01/2020
1	EnzymesIBA 01/2020
1	Expectorants (Mucolytics)IBA 01/2020
1	InterleukinsIBA 01/2020
1	ProdrugsIBA 01/2020
1	leukotriene A4 hydrolaseIBA 01/2020
1	Terbinafine (Lamisil)FDA LinkGeneric 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	Leukocyte Elastase (Neutrophil Elastase)IBA 01/2020
1	Interleukin-10 (Interleukin 10)IBA 01/2020
1	Nitric Oxide DonorsIBA 01/2020
1	VX-659IBA 10/2018
1	GasesIBA 09/2018
1	Interleukin-8 (Interleukin 8)IBA 01/2018
1	Antimicrobial PeptidesIBA 01/2018
1	Vitamin D FDA LinkGeneric 01/2018
1	Aspartic Acid (Aspartate)FDA Link 01/2018
1	clonidine-displacing substance (ClDS)IBA 01/2018
1	Alanine Transaminase (SGPT)IBA 01/2018
1	N-(3-oxododecanoyl)homoserine lactoneIBA 12/2017
1	Amikacin (A.M.K)FDA LinkGeneric 01/2017
1	Levofloxacin (Levaquin)FDA Link 01/2017
1	Fosfomycin FDA Link 01/2017
1	Cysteamine (Mercaptamine)FDA Link 01/2017
1	allyl sulfideIBA 01/2017
1	GalliumIBA 01/2017
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2017
1	Cyanides (Isocyanides)IBA 11/2014
1	AerosolsIBA 12/2013
1	Antiviral Agents (Antivirals)IBA 03/2013
1	Interleukin-17 (Interleukin 17)IBA 07/2011

Therapy/Procedure

31	Therapeutics 10/2023 - 09/2008
1	Polypharmacy 07/2022
1	Precision Medicine 01/2021
1	High-Protein Diet 01/2020
1	Drug Therapy (Chemotherapy) 03/2018
1	Immunotherapy 01/2017